Autoimmune encephalitis: recent clinical and biological advances

Area of Science:

• Neurology
• Immunology
• Neurobiology

Background:

• The field of autoantibody-associated neurological diseases has rapidly expanded since 2015.
• Advances include refined clinical phenotypes, new autoantibody discoveries, and deeper understanding of disease pathways.

Purpose of the Study:

• To provide an updated comprehensive review of autoantibody-associated neurological diseases.
• To integrate clinical diagnosis, patient management, and biological insights for current and future patient care.

Main Methods:

• Review and synthesis of recent literature and clinical findings.
• Analysis of advancements in understanding immunological and neurobiological mechanisms.
• Assessment of evolving diagnostic and therapeutic strategies.

Main Results:

• Increased awareness of distinctive clinical phenotypes aids disease recognition.
• Effective immunotherapies are available, making these 'not to miss' conditions.
• Developing methods to assess patient responses to immunotherapy is an area of growing interest.

Conclusions:

• Autoantibody-associated neurological diseases require prompt recognition and management.
• Integrating clinical, biological, and therapeutic advancements is key to improving patient outcomes.
• This update provides a cohesive view for optimal patient care in 2023 and beyond.